[1] 国家心血管病中心. 中国心血管健康与疾病报告2023[R]. 2024.
[2] MARTINSS, ADAYAW, ALMARZOOQZI, et al. 2024 heart disease and stroke statistics: areport of US and global data from the American heart association[J]. Circulation, 2024, 149(8):e347-e913.
[3] LIK C, HUANGL P, TIANM Y, et al. Cost-effectiveness of a household salt substitution intervention: findings from 20 995 participants of the salt substitute and stroke study[J]. Circulation, 2022, 145(20):1534-1541. doi:  10.1161/CIRCULATIONAHA.122.059573
[4] QUAN J C, PANG D, LIT K, et al. Risk prediction scores for mortality, cerebrovascular, and heart disease among Chinese people with type 2 diabetes[J]. 2019, 104(12): 5823-5830.
[5] ALLOUBANI A, NIMER R, SAMARA R. Relationship between hyperlipidemia, cardiovascular disease and stroke: asystematic review[J]. Curr Cardiol Rev, 2021, 17(6):e051121189015. doi:  10.2174/1573403X16999201210200342
[6] REAMYB V, FORD B, GOODMAN C. Novel pharmacotherapies for hyperlipidemia[J]. Prim Care, 2024, 51(1):27-40. doi:  10.1016/j.pop.2023.08.002
[7] 陈敏先, 姚克裘, 周曾绮, 等. “血通胶囊”治疗高脂血症、高粘滞血症的临床观察[J]. 江苏中医, 1997, 29(10):13-14.
[8] 姚克裘, 周曾绮, 陈敏先. 血通胶囊对老年高脂血症影响的临床研究[J]. 上海中医药杂志, 1995, 29(1):37-38.
[9] MAO T H, ZHANG C X, YANG S, et al. Semaglutide alters gut microbiota and improves NAFLD in db/db mice[J]. BiochemBiophys Res Commun, 2024, 710:149882. doi:  10.1016/j.bbrc.2024.149882
[10] DING J, XU M, DU W, et al. Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice[J]. Int J Biol Sci, 2023, 19(6):1941-1954. doi:  10.7150/ijbs.80122
[11] WU S H, ZHOU YY, WANG Y, et al. Therapeutic potentials of medicinal leech in Chinese medicine[J]. 2024, 52(4): 1027-1051.
[12] LV Q, LI M Y, WEN Z Y, et al. Efficacy and potential mechanism of atherosclerosis prevention by the active components of leech based on network pharmacology combined with animal experiments[J]. Heliyon, 2024, 10(6):e27461. doi:  10.1016/j.heliyon.2024.e27461
[13] YAO M, LI J M, HE M Z, et al. Investigation and identification of the multiple components of Rheum officinaleBaill. using ultra-high-performance liquid chromatography coupled with quadrupole-time-of-flight tandem mass spectrometry and data mining strategy[J]. J Sep Sci, 2021, 44(3):681-690. doi:  10.1002/jssc.202000735
[14] WU L J, WANG X J, JIANG J H, et al. Mechanism of rhubarb in the treatment of hyperlipidemia: a recent review[J]. Open Med, 2023, 18(1):20230812. doi:  10.1515/med-2023-0812
[15] LIN L F, NI B R, LIN H M, et al. Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb. : a review[J]. J Ethnopharmacol, 2015, 159:158-183. doi:  10.1016/j.jep.2014.11.009
[16] TEKA T, WANG L M, GAO J, et al. Polygonum multiflorum: Recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms[J]. J Ethnopharmacol, 2021, 271:113864. doi:  10.1016/j.jep.2021.113864
[17] MAHEMUTI N, JING X Y, ZHANG N J, et al. Association between systemic immunity-inflammation index and hyperlipidemia: apopulation-based study from the NHANES(2015-2020)[J]. Nutrients, 2023, 15(5):1177. doi:  10.3390/nu15051177
[18] ATTIQ A, AFZAL S, AHMAD W, et al. Hegemony of inflammation in atherosclerosis and coronary artery disease[J]. Eur J Pharmacol, 2024, 966:176338. doi:  10.1016/j.ejphar.2024.176338
[19] AUGUET T, BERLANGA A, GUIU-JURADO E, et al. Molecular pathways in non-alcoholic fatty liver disease[J]. Clin Exp Gastroenterol, 2014: 221.